N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C41H44F3N9O4 — CID 167156743

IUPACN-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCc1cc2nn(C3CCC(CN4CC5CCC(C4)N5c4cccc5c4n(C)c(=O)n5C4CCC(=O)NC4=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C41H44F3N9O4/c1-23-17-31-25(18-30(23)46-38(55)29-5-3-8-35(45-29)41(42,43)44)20-51(48-31)26-11-9-24(10-12-26)19-50-21-27-13-14-28(22-50)52(27)32-6-4-7-33-37(32)49(2)40(57)53(33)34-15-16-36(54)47-39(34)56/h3-8,17-18,20,24,26-28,34H,9-16,19,21-22H2,1-2H3,(H,46,55)(H,47,54,56)
InChIKeyMWLVQDUQGZRIIH-UHFFFAOYSA-N
MW783.86 g/mol
LogP5.73
Rot. Bonds7

About N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 167156743) has the molecular formula C41H44F3N9O4 and a molecular weight of 783.86 g/mol. Its IUPAC name is N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID167156743
Molecular FormulaC41H44F3N9O4
Molecular Weight783.86 g/mol
Exact Mass783.35
IUPAC NameN-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCc1cc2nn(C3CCC(CN4CC5CCC(C4)N5c4cccc5c4n(C)c(=O)n5C4CCC(=O)NC4=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C41H44F3N9O4/c1-23-17-31-25(18-30(23)46-38(55)29-5-3-8-35(45-29)41(42,43)44)20-51(48-31)26-11-9-24(10-12-26)19-50-21-27-13-14-28(22-50)52(27)32-6-4-7-33-37(32)49(2)40(57)53(33)34-15-16-36(54)47-39(34)56/h3-8,17-18,20,24,26-28,34H,9-16,19,21-22H2,1-2H3,(H,46,55)(H,47,54,56)
InChIKeyMWLVQDUQGZRIIH-UHFFFAOYSA-N
XLogP5.73
TPSA139.39 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500783.86
LogP ≤ 55.73
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 167156743) is N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is Cc1cc2nn(C3CCC(CN4CC5CCC(C4)N5c4cccc5c4n(C)c(=O)n5C4CCC(=O)NC4=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is MWLVQDUQGZRIIH-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H44F3N9O4/c1-23-17-31-25(18-30(23)46-38(55)29-5-3-8-35(45-29)41(42,43)44)20-51(48-31)26-11-9-24(10-12-26)19-50-21-27-13-14-28(22-50)52(27)32-6-4-7-33-37(32)49(2)40(57)53(33)34-15-16-36(54)47-39(34)56/h3-8,17-18,20,24,26-28,34H,9-16,19,21-22H2,1-2H3,(H,46,55)(H,47,54,56).
What are the key properties of N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 783.86 g/mol, XLogP of 5.73, 7 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[8-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]methyl]cyclohexyl]-6-methylindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 167156743), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).